With a price-to-sales (or “P/S”) ratio of 0.4x Evolent Health, Inc. (NYSE:EVH) may be sending very bullish signals at the moment, given that almost half of all the Healthcare Services companies in the United States have P/S ratios greater than 3.2x and even P/S higher than 17x are not unusual. Although, it’s not wise to just take the P/S at face value as there may be an explanation why it’s so limited.

We’ve found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free.

See our latest analysis for Evolent Health

How Has Evolent Health Performed Recently?

While the industry has experienced revenue growth lately, Evolent…